Back to News
Market Impact: 0.2
How Much Upside is Left in Seaport Therapeutics, Inc (SPTX)? Wall Street Analysts Think 77.91%
Source: zacks.com
Analyst InsightsAnalyst EstimatesHealthcare & Biotech
Analysts’ mean price target for Seaport Therapeutics (SPTX) implies 77.9% upside, though the article notes this metric has not been reasonably effective. Strong agreement among analysts in raising earnings estimates is presented as a more meaningful indication of potential upside.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
SPTX0.35
More News
- We're raising our price target on Cardinal Health after another stellar quarter of profits
- Pale Fire Capital SE acquires $31.45m Coursera stock
- IonQ climbs 3% on earnings beat and raised guidance
- Here's where we stand on Kimberly-Clark shares after a better-than-feared quarter
- Why is SPDR S&P 500 ETF Trust sliding today?
- White Mountains subsidiary sells $76.4 million in MediaAlpha stock